Dr. Christopher L. Hallemeier, M.D.
Claim this profileMayo Clinic
Area of expertise
Esophageal Adenocarcinoma
Christopher L. Hallemeier, M.D. has run 2 trials for Esophageal Adenocarcinoma. Some of their research focus areas include:
Gastroesophageal Junction Adenocarcinoma
Christopher L. Hallemeier, M.D. has run 2 trials for Gastroesophageal Junction Adenocarcinoma. Some of their research focus areas include:
Affiliated Hospitals
Mayo Clinic
Mayo Clinic In Rochester
Clinical Trials Christopher L. Hallemeier, M.D. is currently running
Proton Therapy vs Photon Radiation
for Esophageal Cancer
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Recruiting
2 awards
Phase 3
1 criteria
Radiotherapy + Chemotherapy
for Esophageal Cancer
This phase II trial tests how well preoperative (prior to surgery) radiation therapy with fluorouracil, oxaliplatin, and leucovorin calcium (FOLFOX) works for the treatment of stage I-III esophageal or gastroesophageal junction adenocarcinoma. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Fluorouracil stops cells from making deoxyribonucleic acid (DNA) and it may kill tumor cells. Leucovorin is not a chemotherapy medication but is given in conjunction with chemotherapy. Leucovorin is used with the chemotherapy medication fluorouracil to enhance the effects of the fluorouracil, in other words, to make the drug work better. Oxaliplatin is in a class of medications called platinum-containing antineoplastic agents. It damages the cell's DNA and may kill tumor cells. Giving preoperative hypofractionated radiation with fluorouracil and oxaliplatin may kill more tumor cells in patients with stage I-III esophageal or gastroesophageal junction adenocarcinoma.
Recruiting
1 award
Phase 2
9 criteria
More about Christopher L. Hallemeier, M.D.
Clinical Trial Related
6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Christopher L. Hallemeier, M.D. has experience with
- Fluorouracil
- Hypofractionated Radiation Therapy
- Leucovorin Calcium
- Oxaliplatin
- Doxorubin
- Stereotactic Body Radiation Therapy (SBRT)
Breakdown of trials Christopher L. Hallemeier, M.D. has run
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Esophageal cancer
Liver Cancer
Hepatocellular Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher L. Hallemeier, M.D. specialize in?
Christopher L. Hallemeier, M.D. focuses on Esophageal Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma. In particular, much of their work with Esophageal Adenocarcinoma has involved Stage I patients, or patients who are Stage II.
Is Christopher L. Hallemeier, M.D. currently recruiting for clinical trials?
Yes, Christopher L. Hallemeier, M.D. is currently recruiting for 2 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Christopher L. Hallemeier, M.D. has studied deeply?
Yes, Christopher L. Hallemeier, M.D. has studied treatments such as Fluorouracil, Hypofractionated Radiation Therapy, Leucovorin Calcium.
What is the best way to schedule an appointment with Christopher L. Hallemeier, M.D.?
Apply for one of the trials that Christopher L. Hallemeier, M.D. is conducting.
What is the office address of Christopher L. Hallemeier, M.D.?
The office of Christopher L. Hallemeier, M.D. is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.